Biostage Revenue and Competitors
Estimated Revenue & Valuation
- Biostage's estimated annual revenue is currently $2.3M per year.
- Biostage's estimated revenue per employee is $155,000
Employee Data
- Biostage has 15 Employees.
- Biostage grew their employee count by -37% last year.
Biostage's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Business Development and Operations | Reveal Email/Phone |
2 | President | Reveal Email/Phone |
Biostage Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Biostage?
Biostage is a bioengineering company that is developing next-generation esophageal implants. The Company's Cellspan technology combines a proprietary, biocompatible scaffold with a patient's own cells to create an esophageal implant that could potentially be used to treat pediatric esophageal atresia and other conditions that affect the esophagus. These implants have the potential to dramatically improve the quality of life for children and adults. At Biostage, we believe the future of medicine has been inside us all along. For more information, please visit www.biostage.com.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Holliston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 20 | 0% | N/A |
#2 | $4.3M | 28 | -32% | N/A |
#3 | $5.3M | 28 | 0% | N/A |
#4 | $7M | 28 | -3% | N/A |
#5 | $5M | 29 | 4% | N/A |